Bcl-2-IN-11
Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. Bcl-2-IN-11 shows weak inhibition of Bcl-xl (IC50 > 1000 nM) . Bcl-2-IN-11 can be used for the research of a variety of cancers caused by abnormal overexpression of Bcl-2 family proteins: especially malignant hematologic diseases of acute lymphoid leukemia, etc. Bcl-2-IN-11 can also avoid toxic side effects caused by Bcl-xl inhibition, such as thrombocytopenia[1].
Product Specifications
CAS Number
[2760536-88-5]
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl-2-in-11.html
Solubility
10 mM in DMSO
Smiles
O=S(NC(C(C=CC(N1C[C@H](N(CC1)CC2=C(C3=CC=C(C=C3)Cl)CC(C)(CC2)C)C)=C4)=C4OC5=CN=C(NC=C6)C6=C5)=O)(C7=CC([N+]([O-])=O)=C(C(F)=C7)NC[C@H]8COCCO8)=O
Molecular Formula
C45H49ClFN7O8S
Molecular Weight
902.43
References & Citations
[1]Kong Xianglong, et al. Heterocyclic compound as bcl-2 inhibitor. WO2022028353A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bcl-2; Bcl-xL
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PCNA (Proliferating Cell Nuclear antigen, MGC8367) (MaxLight 750) discontinued
Recombinant Bacillus halodurans Protoheme IX farnesyltransferase (ctaB), partial
